StartUPDATES is a member feature of MedCitizens, a community of MedCity News startups. Submit here and join.
AI-enabled health insights company Cardinal Analytx Solutions this week closed a $22 million Series B round led by John Doerr, who will also join the Cardinal Analytx board of directors along with founder Nigam Shah. Joining the round were strategic investors GuideWell Mutual Holding Corporation, Blue Shield California and Premera Blue Cross. The funds will be used to rapidly extend Cardinal’s lead in the innovative use of machine learning to drive proactive healthcare through investments in talent and technology.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
“We take great pleasure in welcoming John Doerr to our board and are honored by the investments from his family fund, our strategic health plan partners and other leading investors,” said Cardinal Analytx CEO Linda T. Hand. “The new growth funding positions us to capitalize on our early commercial traction and robust pipeline. We expect to quickly extend our leadership in the use of AI to accurately predict rising risk and future costs, and deliver actionable insights.”
The Cardinal Analytx solution enables providers and plans to look around the corner to predict which individuals could be at risk of worsening health and rising cost, and helps clinicians steer them toward better health outcomes.
Neuro Rehab VR develops virtual reality training exercises to help aid and expedite neurological physical therapy recovery by leveraging breakthroughs in neuroplasticity. The VR exercises are designed with the help of physical therapists and customized for each patient’s needs and targeted therapy plan with the ability to measure, quantify, and track progress with real-time data feedback.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
UnityPoint Health, a network of hospitals, clinics and home care services in Iowa, Illinois and Wisconsin, has launched a $100 million venture fund, which will focus on early-stage growth companies across digital health, medical devices, therapeutic spaces and healthcare services. The group made the announcement at the MedCity INVEST Pop Health conference in New Orleans this week. Click here to read more.
Image: Getty Images
